Hilltone Software Plans 5% Stake in RegTech Firm Rzolut Amid IT Deals

TECH
Whalesbook Corporate News Logo
AuthorAarav Shah|Published at:
Hilltone Software Plans 5% Stake in RegTech Firm Rzolut Amid IT Deals
Overview

Hilltone Software & Gases is considering a ~5% investment in Rzolut Technologies, a RegTech startup. This aims to enhance Hilltone's IT division by integrating Rzolut's AI compliance platform and customer base. The company also renewed IT contracts, including a ₹43.89 lakh software license and a US$25,000 deal with Versante Health. The Rzolut deal requires successful due diligence and valuation, and the startup is not yet profitable.

Instant Stock Alerts on WhatsApp

Used by 10,000+ active investors

1

Add Stocks

Select the stocks you want to track in real time.

2

Get Alerts on WhatsApp

Receive instant updates directly to WhatsApp.

  • Quarterly Results
  • Concall Announcements
  • New Orders & Big Deals
  • Capex Announcements
  • Bulk Deals
  • And much more

Hilltone Software Considers Rzolut Stake, Renews IT Contracts

Hilltone Software & Gases Limited's board has discussed a proposal to acquire approximately 5% of Rzolut Technologies Pte. Ltd., an early-stage RegTech startup. This strategic move, pending due diligence and valuation, aims to integrate Rzolut's AI-driven compliance platform into Hilltone's IT vertical.

The company also reported successful renewals within its IT division. These include a software license agreement worth ₹43.89 lakh and a US$25,000 (approximately ₹23 lakh) contract for software updates with Versante Health. Rzolut Technologies, based in Singapore and India, reported a turnover of ₹5.00 crore for FY24-25.

Key Developments

The board of Hilltone Software & Gases Ltd reviewed the potential investment in Rzolut Technologies, a startup specializing in compliance and risk management solutions. The proposed stake is around 5% of Rzolut.

Alongside this, Hilltone's IT operations secured contract renewals: a ₹43.89 lakh software license and a ₹23 lakh deal with Versante Health for software updates.

Why This Matters

This potential investment could significantly enhance Hilltone's IT vertical by bringing in Rzolut's AI compliance technology and its established customer base. Leveraging Rzolut's founders and technology could accelerate growth in Hilltone's software segment. The IT contract renewals also provide stable revenue streams.

Company Background

Hilltone Software & Gases Ltd is a diversified company involved in industrial gases, software, and eco-energy, with recent focus on expanding its industrial gases business.

Rzolut Technologies, founded in 2022, is a RegTech startup focused on AI-driven compliance and risk management. It secured $1.25 million in seed funding in early 2025 but has not yet reached profitability.

Notably, Hilltone Software & Gases itself faces significant challenges. MarketsMOJO rated the stock 'Strong Sell' in March 2026 due to weak financial fundamentals, including zero Return on Equity and negative profit growth. The company has also faced previous Income Tax search actions.

Strategic Benefits

The acquisition of a stake in Rzolut offers Hilltone:

  • Entry into the growing RegTech sector.
  • Access to Rzolut's AI-driven data intelligence platform.
  • Potential new revenue streams through Rzolut's clientele.
  • Strengthened capabilities and market presence for its IT division.

Risks to Watch

The Rzolut investment is subject to satisfactory due diligence and valuation. As an early-stage company, Rzolut has not yet achieved profitability. Hilltone's own weak financial health and recent 'Strong Sell' rating add considerable risk to the potential deal.

Peer Comparison

Rzolut operates in the RegTech space, where peers like India's IRIS Business Services and IDfy focus on compliance and verification. Larger Indian IT firms such as TCS and Wipro offer broader data analytics but are in a different scale of operation.

What to Track Next

Investors will monitor the completion of Rzolut's due diligence and the final valuation. Progress and revenue from the Versante Health contract will also be key. Updates on Rzolut's path to profitability will be important.

Get stock alerts instantly on WhatsApp

Quarterly results, bulk deals, concall updates and major announcements delivered in real time.

Disclaimer:This content is for educational and informational purposes only and does not constitute investment, financial, or trading advice, nor a recommendation to buy or sell any securities. Readers should consult a SEBI-registered advisor before making investment decisions, as markets involve risk and past performance does not guarantee future results. The publisher and authors accept no liability for any losses. Some content may be AI-generated and may contain errors; accuracy and completeness are not guaranteed. Views expressed do not reflect the publication’s editorial stance.